<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230926059523N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-30</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Bi unicondylar knee arthroplasty versus Total knee arthroplasty: A Randomized Clinical Trial</public_title>
      <acronym></acronym>
      <scientific_title>Bi unicondylar knee arthroplasty versus Total knee arthroplasty: A Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-12-16</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>26</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72824</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The patients included in the study will be randomly divided into two groups, TKA and bi-uncondylar knee arthroplasty, using the block randomization method.

First, the leg that has the most pain is subjected to TKA. The other category of foot that has the most pain is subjected to bi-UKA operation. Demographic, radiological, and laboratory characteristics will be compared between the two groups.

After 1 month and 6 months from the last operation, the patient is followed up with frequent visits. And questionnaires related to patient function and pain will be filled for both legs. Then, a comparison will be made between the two groups as well as between the two models.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Knee osteoarthritis - knee joint replacement.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The leg that has the most pain is subjected to bi-UKA operation in such a way that the medial and lateral condyles of the knee are replaced with unicondylar prostheses and the anterior cruciate ligament is not damaged. (bi unicondylar knee arthroplasty) in this method. While preserving the cruciate ligament, only the medial and lateral condyles that are damaged in the arthritic process are replaced with medial and lateral unicondylar prostheses (an improved process for both condyles, compared to what is done in UKA), in order to establish proper alignment. joint, the process of replacing the joint with less damage to the healthy ligament structure (ACL) and with the aim of improving the performance of patients after surgery. Intervention 2: Control group:The leg that has the most pain is subjected to TKA.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Individual data of participants including radiological angles, scores of questionnaires

When:
The access period starts 1 year after the results are published

To whom:
The data will be available only to researchers working in academic and scientific institutions

Conditions:
Determining a treatment plan and modeling to perform a similar action in patients who benefit more from bi-UKA

Where to obtain:
Contact by email alighaneitehrani@sbmu.ac.ir

How to obtain:
Sending an e-mail, introducing the organization or responsible person, expressing the work context and goals of accessing information and sending data within a period of 3-6 weeks

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>ali ghanei tehrani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Madani Street, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1617763141</zip>
        <telephone>+98 21 7343 0000</telephone>
        <email>alighaneitehrani@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>alighaneitehrani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Hossein Square, Shahid Madani Street, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1617763141</zip>
        <telephone>+98 21 7343 0000</telephone>
        <email>alighaneitehrani@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with medial and lateral OA suitable for treatment with standard unrestricted TKA
Healthy cruciate ligaments (based on radiological evidence and clinical examination)
Willing and able to provide informed consent</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with rheumatoid arthritis or other inflammatory arthropathy
Varus or valgus deformity greater than 15 degrees
Flexion contracture greater than 10 degrees
Single-compartment OA suitable for isolated UKA
Radiological evidence of Kelgren and Lawrence grade III OA of the patellar joint
Patients who had undergone previous knee surgery that might affect the outcome of the arthroplasty, such as anterior or posterior cruciate ligament reconstruction
Who had significant OA of the spine or other lower extremity joints were not included in the study
Despite the diagnostic measures before the operation, if there is a clear ligament damage that makes the condition unfavorable for bi-uka surgery, the patient will be excluded from the study.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17.10</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Unilateral primary osteoarthritis, unspecified knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The leg that has the most pain is subjected to bi-UKA operation in such a way that the medial and lateral condyles of the knee are replaced with unicondylar prostheses and the anterior cruciate ligament is not damaged. (bi unicondylar knee arthroplasty) in this method. While preserving the cruciate ligament, only the medial and lateral condyles that are damaged in the arthritic process are replaced with medial and lateral unicondylar prostheses (an improved process for both condyles, compared to what is done in UKA), in order to establish proper alignment. joint, the process of replacing the joint with less damage to the healthy ligament structure (ACL) and with the aim of improving the performance of patients after surgery.</i_keyword>
      <i_keyword>Control group:The leg that has the most pain is subjected to TKA</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>KOOS (knee injury and osteoarthritis outcome) questionnaire score including daily activity, sports activity, pain, quality of life, symptoms and joint stiffness before and after surgery. Timepoint: After 1 month and 6 months from the last operation, the patient is followed up with frequent visits. And questionnaires related to patient function and pain will be filled for both legs. Method of measurement: Clinical records, pre- and post-surgery graphs,lab tests, questionnaires.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Blood loss during and after surgery. Timepoint: Before, 1 day and 1 week after the operation. Method of measurement: Laboratory data.</sec_outcome>
      <sec_outcome>Duration of surgery. Timepoint: During the operation, from the time of skin incision to wound closure. Method of measurement: clock.</sec_outcome>
      <sec_outcome>Anatomical and mechanical angles and alignment of the knee joint. Timepoint: Before and after surgery. Method of measurement: standing 3-joint Aligment view graphs (hip-knee-ankle).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-09-10</approval_date>
        <contact_name>Research Ethics Committees of Vice-Chancellor in Research Affairs - Shahid Beheshti University of Me</contact_name>
        <contact_address>Shahid Chamran Highway - Yemen St. - Shahid Abbas Arabi St. (Parvaneh) - next to Taleghani Hospital - Shahid Beheshti University of Medical Sciences and Health Care Services - Headquarters Building 2 - 5th Floor - Vice President of Research and Technology Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
